![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Avinger Secures Up to $55 Million in Financing
Avinger Secures Up to $55 Million in Financing
Avinger has reached a term loan agreement and a securities purchase agreement with CRG, which will provide Avinger with new financing of up to $55 million.
Avinger, a provider of image-guided, catheter-based systems for the treatment of peripheral arterial disease, will use proceeds to retire existing debt, fund post-marketing clinical trials and begin broad-scale commercialization of the Pantheris image-guided atherectomy device in 2016, according to the company.
The Pantheris system combines directional atherectomy capabilities with real-time intravascular visualization to remove plaque from blocked arteries.
Redwood City, Calif.-based Avinger recently filed a submission for 510(k) clearance with the FDA to market the system for the treatment of patients with peripheral arterial diseases. — Michael Cipriano
Upcoming Events
-
21Oct